Candy Kumps

2.1k total citations
30 papers, 698 citations indexed

About

Candy Kumps is a scholar working on Neurology, Molecular Biology and Oncology. According to data from OpenAlex, Candy Kumps has authored 30 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Neurology, 10 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Candy Kumps's work include Neuroblastoma Research and Treatments (13 papers), Lung Cancer Research Studies (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Candy Kumps is often cited by papers focused on Neuroblastoma Research and Treatments (13 papers), Lung Cancer Research Studies (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Candy Kumps collaborates with scholars based in Belgium, Germany and Spain. Candy Kumps's co-authors include Frank Speleman, Katleen De Preter, Jo Vandesompele, Frank Westermann, Pieter Mestdagh, Angelika Eggert, Johannes H. Schulte, Björn Menten, Alexander Schramm and Nadine Van Roy and has published in prestigious journals such as Bioinformatics, PLoS ONE and Oncogene.

In The Last Decade

Candy Kumps

30 papers receiving 689 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Candy Kumps Belgium 13 424 290 241 119 90 30 698
Anneleen Beckers Belgium 14 530 1.3× 296 1.0× 228 0.9× 65 0.5× 44 0.5× 20 777
Maura Diamond United States 11 498 1.2× 436 1.5× 629 2.6× 199 1.7× 155 1.7× 14 914
Beatriz Walter United States 15 357 0.8× 296 1.0× 71 0.3× 123 1.0× 43 0.5× 21 717
Angela Di Vinci Italy 19 452 1.1× 311 1.1× 152 0.6× 255 2.1× 105 1.2× 42 922
Jerry C. Cheng United States 14 387 0.9× 108 0.4× 61 0.3× 136 1.1× 66 0.7× 28 707
Eva Rodríguez Spain 12 272 0.6× 92 0.3× 205 0.9× 77 0.6× 41 0.5× 23 467
Masashi Nomura Japan 13 361 0.9× 280 1.0× 76 0.3× 68 0.6× 127 1.4× 54 719
Gudrun Zulehner Austria 15 409 1.0× 159 0.5× 180 0.7× 272 2.3× 30 0.3× 46 946
Laura S. Danielson United States 12 339 0.8× 170 0.6× 119 0.5× 69 0.6× 27 0.3× 24 567
Swann Gaulis Switzerland 9 424 1.0× 47 0.2× 377 1.6× 95 0.8× 80 0.9× 13 929

Countries citing papers authored by Candy Kumps

Since Specialization
Citations

This map shows the geographic impact of Candy Kumps's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Candy Kumps with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Candy Kumps more than expected).

Fields of papers citing papers by Candy Kumps

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Candy Kumps. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Candy Kumps. The network helps show where Candy Kumps may publish in the future.

Co-authorship network of co-authors of Candy Kumps

This figure shows the co-authorship network connecting the top 25 collaborators of Candy Kumps. A scholar is included among the top collaborators of Candy Kumps based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Candy Kumps. Candy Kumps is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kumps, Candy, Sarah Vergult, Rudy Van Coster, et al.. (2020). Phenotypic spectrum of the RBM10 ‐mediated intellectual disability and congenital malformation syndrome beyond classic TARP syndrome features. Clinical Genetics. 99(3). 449–456. 10 indexed citations
3.
Mus, Liselot, Irina Lambertz, Candy Kumps, et al.. (2020). The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness. Scientific Reports. 10(1). 218–218. 19 indexed citations
4.
Kumps, Candy, et al.. (2019). Nocturnal voiding frequency does not describe nocturia‐related bother. Neurourology and Urodynamics. 38(6). 1648–1656. 5 indexed citations
5.
Claeys, Tom, Nicolaas Lumen, Candy Kumps, et al.. (2017). The independent oncological role for cytoreductive nephrectomy in metastatic renal cell carcinoma: Prognostic features in the era of targeted therapies. Urologic Oncology Seminars and Original Investigations. 35(4). 152.e13–152.e22. 2 indexed citations
6.
Claeys, Tom, Bert Dhondt, Filip Poelaert, et al.. (2017). Prognostic and Therapeutic Implications of Circulating Androgen Receptor Gene Copy Number in Prostate Cancer Patients Using Droplet Digital Polymerase Chain Reaction. Clinical Genitourinary Cancer. 16(3). 197–205.e5. 7 indexed citations
7.
Kumps, Candy, et al.. (2017). Circadian Variation in Post Void Residual in Nursing Home Residents With Moderate Impairment in Activities of Daily Living. Journal of the American Medical Directors Association. 18(5). 433–437. 5 indexed citations
8.
Hervé, François, et al.. (2017). Clean Intermittent Self-Catheterization as a Treatment Modality for Urinary Retention: Perceptions of Urologists. International Neurourology Journal. 21(3). 189–196. 8 indexed citations
9.
Poelaert, Filip, Candy Kumps, Nicolaas Lumen, et al.. (2017). Androgen Receptor Gene Copy Number and Protein Expression in Treatment-Naïve Prostate Cancer. Urologia Internationalis. 99(2). 222–228. 2 indexed citations
10.
Althoff, Kristina, Anneleen Beckers, Emma Bell, et al.. (2014). A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies. Oncogene. 34(26). 3357–3368. 87 indexed citations
11.
Rihani, Ali, Tom Van Maerken, Filip Pattyn, et al.. (2013). Effective Alu Repeat Based RT-Qpcr Normalization in Cancer Cell Perturbation Experiments. PLoS ONE. 8(8). e71776–e71776. 12 indexed citations
12.
Beckers, Anneleen, Maté Ongenaert, Anneleen Decock, et al.. (2012). MiR-137 is epigenetically silenced in MYCN amplified neuroblastomas and targets the polycomb repressive complex 2 (PRC2) component EZH2. Ghent University Academic Bibliography (Ghent University). 1 indexed citations
13.
Schulte, Johannes H., Lukas C. Heukamp, Theresa Thor, et al.. (2012). ALK(F1174L) is a driving oncogene of neuroblastoma in transgenic mice. Pediatric Blood & Cancer. 59(6). 989–989. 1 indexed citations
14.
Afanasyeva, Elena, Pieter Mestdagh, Candy Kumps, et al.. (2011). MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival. Cell Death and Differentiation. 18(6). 974–984. 128 indexed citations
15.
Vandewoestyne, Mado, Candy Kumps, Katrien Swerts, et al.. (2011). Isolation of disseminated neuroblastoma cells from bone marrow aspirates for pretreatment risk assessment by array comparative genomic hybridization. International Journal of Cancer. 130(5). 1098–1108. 6 indexed citations
16.
Fieuw, Annelies, Candy Kumps, Alexander Schramm, et al.. (2011). Identification of a novel recurrent 1q42.2‐1qter deletion in high risk MYCN single copy 11q deleted neuroblastomas. International Journal of Cancer. 130(11). 2599–2606. 34 indexed citations
17.
Castelletti, Deborah, Giulio Fiaschetti, Valeria Di Dato, et al.. (2010). The Quassinoid Derivative NBT-272 Targets Both the AKT and ERK Signaling Pathways in Embryonal Tumors. Molecular Cancer Therapeutics. 9(12). 3145–3157. 11 indexed citations
18.
Kumps, Candy, Nadine Van Roy, Lien Heyrman, et al.. (2010). Multiplex Amplicon Quantification (MAQ), a fast and efficient method for the simultaneous detection of copy number alterations in neuroblastoma. BMC Genomics. 11(1). 298–298. 21 indexed citations
19.
Mestdagh, Pieter, Erik Fredlund, Filip Pattyn, et al.. (2009). MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors. Oncogene. 29(9). 1394–1404. 102 indexed citations
20.
Speleman, Frank, et al.. (2008). Copy number alterations and copy number variation in cancer: close encounters of the bad kind. Cytogenetic and Genome Research. 123(1-4). 176–182. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026